Citizens Reiterates Market Outperform on BeOne Medicines, Maintains $396 Price Target

Benzinga Newsdesk www.benzinga.com Negative 81.0%

Neg 81% Neu 0% Pos 0%

Citizens analyst Reni J. Benjamin reiterates BeOne Medicines (NASDAQ:ONC) with a Market Outperform and maintains $396 price target.